Point of Care Diagnostics Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Purchase Mode, Sample, End User and Geography

Description

List of Tables

The Point of Care Diagnostics Market is expected to reach US$ 88.83 Bn by 2031 from US$ 37.93 Bn in 2024; the market is estimated to grow at a CAGR of 13.0% during 2025-2031. Major factors driving the market growth include increasing prevalence of infectious diseases and key product launches and developments. However, product recalls among the market deterrents.

Point-of-care testing (POCT) is critical for the diagnosis, treatment, and prevention of infectious diseases. It can be used to detect major pathogens, including human immunodeficiency virus (HIV), malarial parasites, human papillomavirus (HPV), Ebola, dengue, and Zika viruses, and Mycobacterium tuberculosis (TB bacteria). According to the World Health Organization (WHO) data, 1.3 million people (including 214,000 individuals affected by HIV) succumbed to TB in 2022. Its estimates also indicate that 10.6 million individuals in the world will have TB in 2022, including 3.5 million women, 1.3 million children, and 5.8 million men. Additionally, 30 countries with high TB burdens contributed 86-90% of new TB cases during 2022. Eight countries contributed two-thirds of the total, with India leading the way, followed by the Philippines, China, Indonesia, Pakistan, Nigeria, Bangladesh, and South Africa. As per the WHO, HIV has infected over 39.9 million people worldwide. In 2023, people were diagnosed with HIV, out of which 1.3 million people were newly diagnosed, including 77% adults and 57% children. According to a study published by Joint United Nations Programme on HIV/AIDS (UNAIDS) in 2023, ~630,000 people died due to HIV and associated conditions. As per the European Centre for Disease Prevention and Control, ~2.6 million people in Europe were infected with HIV in 2023. Healthcare-associated infections (HAIs), including central line-associated bloodstream infections and catheter-associated urinary tract infections (UTIs), might affect patients in hospitals and other healthcare facilities. According to WHO, ~9 million HAIs occur every year and cause nearly 25 million additional hospitalization days in Europe yearly. As per the same source, HAI leads to an additional financial burden of approximately US$ 14.0-26.0 billion in Europe each year. As per the Office of Disease Prevention and Health Promotion, 1 out of 31 hospitalizations in the US suffer from HAI at any given time. Thus, the increasing prevalence of infectious diseases is expected to create a demand for point-of-care test diagnostics worldwide.

The comparative company analysis evaluates and categorizes the point of care diagnostics market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global Point of Care Diagnostics Market. The key market players are F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Abbott Laboratories, QIAGEN NV, Siemens AG, BD, bioMerieux SA, Polymer Technology Systems, Inc. (PTS), Nova Biomedical Corporation, Danaher Corp

The point of care diagnostics market, based on product, is divided into glucose monitoring, infectious disease testing, cardiometabolic testing, pregnancy and fertility testing, coagulation testing, tumor/cancer marker testing, cholesterol testing, urinalysis testing, hematology testing, thyroid testing, others. The glucose monitoring segment held the largest share of the Point of Care Diagnostics Market in 2024, and it is expected to register the highest CAGR during 2025-2031. Based on purchase mode, the point of care diagnostics market is segmented into OTC and Prescription. In 2024, the Prescription segment held the largest share of the market. Based on sample, the point of care diagnostics market is segmented into blood, urine, others. In 2024, the Blood segment held the largest share of the market. Based on end user, the point of care diagnostics market is segmented into healthcare facilities, homecare, and others. In 2024, the healthcare facilities segment held the largest share of the market.

Various organic and inorganic strategies are adopted by companies operating in the Point of Care Diagnostics Market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few of the significant developments by key players in the Point of Care Diagnostics Market are listed below.

In July 2024, Roche the completion of the acquisition of LumiraDx's Point of Care technology, following the receipt of all required antitrust and regulatory clearances. Roche will now embark on the full integration of the company's innovative multi-assay point of care platform and the related R&D, operational and commercial sites into its global organization.

Product Code: TIPRE00006394

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Analyst Market Outlook
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Point of Care Diagnostics Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Point of Care Diagnostics Market - Key Market Dynamics

5.1 Point of Care Diagnostics Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Prevalence of Infectious Diseases
- 5.2.2 Key Product Launches and Developments
5.3 Market Restraints
- 5.3.1 Product Recalls
5.4 Market Opportunities
- 5.4.1 Rising Product Launches and Advancements by Market Players in Emerging Economies
5.5 Future Trends
- 5.5.1 Integration Of Artificial Intelligence (AI) and Machine Learning (ML)
5.6 Impact of Drivers and Restraints:

6. Point of Care Diagnostics Market - Global Market Analysis

6.1 Point of Care Diagnostics Market Revenue (US$ Million), 2021-2031
6.2 Point of Care Diagnostics Market Forecast Analysis

7. Point of Care Diagnostics Market Analysis - by Product

7.1 Glucose Monitoring
- 7.1.1 Overview
- 7.1.2 Glucose Monitoring: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Infectious Disease Testing
- 7.2.1 Overview
- 7.2.2 Infectious Disease Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Cardio metabolic Testing
- 7.3.1 Overview
- 7.3.2 Cardio metabolic Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Pregnancy And Fertility Testing
- 7.4.1 Overview
- 7.4.2 Pregnancy And Fertility Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Coagulation Testing
- 7.5.1 Overview
- 7.5.2 Coagulation Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Tumor or Cancer Marker Testing
- 7.6.1 Overview
- 7.6.2 Tumor or Cancer Marker Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.7 Cholesterol Testing
- 7.7.1 Overview
- 7.7.2 Cholesterol Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.8 Urinalysis Testing
- 7.8.1 Overview
- 7.8.2 Urinalysis Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.9 Hematology Testing
- 7.9.1 Overview
- 7.9.2 Hematology Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.10 Thyroid Testing
- 7.10.1 Overview
- 7.10.2 Thyroid Testing: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
7.11 Others
- 7.11.1 Overview
- 7.11.2 Others: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)

8. Point of Care Diagnostics Market Analysis - by Purchase Mode

8.1 OTC
- 8.1.1 Overview
- 8.1.2 OTC: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Prescription
- 8.2.1 Overview
- 8.2.2 Prescription: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)

9. Point of Care Diagnostics Market Analysis - by Sample

9.1 Blood
- 9.1.1 Overview
- 9.1.2 Blood: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Urine
- 9.2.1 Overview
- 9.2.2 Urine: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Others
- 9.3.1 Overview
- 9.3.2 Others: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)

10. Point of Care Diagnostics Market Analysis - by End User

10.1 Healthcare Facilities
- 10.1.1 Overview
- 10.1.2 Healthcare Facilities: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Homecare
- 10.2.1 Overview
- 10.2.2 Homecare: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Others
- 10.3.1 Overview
- 10.3.2 Others: Point of Care Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)

11. Point of Care Diagnostics Market - Geographical Analysis

11.1 Overview
11.2 North America
- 11.2.1 North America Point of Care Diagnostics Market Overview
- 11.2.2 North America: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
- 11.2.3 North America: Point of Care Diagnostics Market Breakdown, by Product
  - 11.2.3.1 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Product
  - 11.2.3.2 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Glucose Monitoring
  - 11.2.3.3 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Infectious Disease Testing
  - 11.2.3.4 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Cardio Metabolic Testing
- 11.2.4 North America: Point of Care Diagnostics Market Breakdown, by Purchase Mode
  - 11.2.4.1 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Purchase Mode
- 11.2.5 North America: Point of Care Diagnostics Market Breakdown, by Sample
  - 11.2.5.1 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Sample
- 11.2.6 North America: Point of Care Diagnostics Market Breakdown, by End User
  - 11.2.6.1 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by End User
  - 11.2.6.2 North America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Healthcare Facilities
- 11.2.7 North America: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 11.2.7.1 North America: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 11.2.7.2 United States: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
    - 11.2.7.2.1 United States: Point of Care Diagnostics Market Breakdown, by Product
    - 11.2.7.2.2 United States: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
    - 11.2.7.2.3 United States: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
    - 11.2.7.2.4 United States: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
    - 11.2.7.2.5 United States: Point of Care Diagnostics Market Breakdown, by Purchase Mode
    - 11.2.7.2.6 United States: Point of Care Diagnostics Market Breakdown, by Sample
    - 11.2.7.2.7 United States: Point of Care Diagnostics Market Breakdown, by End User
    - 11.2.7.2.8 United States: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
  - 11.2.7.3 Canada: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
    - 11.2.7.3.1 Canada: Point of Care Diagnostics Market Breakdown, by Product
    - 11.2.7.3.2 Canada: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
    - 11.2.7.3.3 Canada: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
    - 11.2.7.3.4 Canada: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
    - 11.2.7.3.5 Canada: Point of Care Diagnostics Market Breakdown, by Purchase Mode
    - 11.2.7.3.6 Canada: Point of Care Diagnostics Market Breakdown, by Sample
    - 11.2.7.3.7 Canada: Point of Care Diagnostics Market Breakdown, by End User
    - 11.2.7.3.8 Canada: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
  - 11.2.7.4 Mexico: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
    - 11.2.7.4.1 Mexico: Point of Care Diagnostics Market Breakdown, by Product
    - 11.2.7.4.2 Mexico: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
    - 11.2.7.4.3 Mexico: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
    - 11.2.7.4.4 Mexico: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
    - 11.2.7.4.5 Mexico: Point of Care Diagnostics Market Breakdown, by Purchase Mode
    - 11.2.7.4.6 Mexico: Point of Care Diagnostics Market Breakdown, by Sample
    - 11.2.7.4.7 Mexico: Point of Care Diagnostics Market Breakdown, by End User
    - 11.2.7.4.8 Mexico: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.3 Europe
- 11.3.1 EuropePoint of Care Diagnostics Market Overview
- 11.3.2 Europe: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
- 11.3.3 Europe: Point of Care Diagnostics Market Breakdown, by Product
  - 11.3.3.1 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Product
  - 11.3.3.2 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Glucose Monitoring
  - 11.3.3.3 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Infectious Disease Testing
  - 11.3.3.4 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Cardio Metabolic Testing
- 11.3.4 Europe: Point of Care Diagnostics Market Breakdown, by Purchase Mode
  - 11.3.4.1 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Purchase Mode
- 11.3.5 Europe: Point of Care Diagnostics Market Breakdown, by Sample
  - 11.3.5.1 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Sample
- 11.3.6 Europe: Point of Care Diagnostics Market Breakdown, by End User
  - 11.3.6.1 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by End User
  - 11.3.6.2 Europe: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Healthcare Facilities
- 11.3.7 Europe: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 11.3.7.1 Europe: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 11.3.7.2 United Kingdom: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
    - 11.3.7.2.1 United Kingdom: Point of Care Diagnostics Market Breakdown, by Product
    - 11.3.7.2.2 United Kingdom: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
    - 11.3.7.2.3 United Kingdom: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
    - 11.3.7.2.4 United Kingdom: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
    - 11.3.7.2.5 United Kingdom: Point of Care Diagnostics Market Breakdown, by Purchase Mode
    - 11.3.7.2.6 United Kingdom: Point of Care Diagnostics Market Breakdown, by Sample
    - 11.3.7.2.7 United Kingdom: Point of Care Diagnostics Market Breakdown, by End User
    - 11.3.7.2.8 United Kingdom: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
  - 11.3.7.3 Germany: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
    - 11.3.7.3.1 Germany: Point of Care Diagnostics Market Breakdown, by Product
    - 11.3.7.3.2 Germany: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
    - 11.3.7.3.3 Germany: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
    - 11.3.7.3.4 Germany: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
    - 11.3.7.3.5 Germany: Point of Care Diagnostics Market Breakdown, by Purchase Mode
    - 11.3.7.3.6 Germany: Point of Care Diagnostics Market Breakdown, by Sample
    - 11.3.7.3.7 Germany: Point of Care Diagnostics Market Breakdown, by End User
    - 11.3.7.3.8 Germany: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
  - 11.3.7.4 France: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
    - 11.3.7.4.1 France: Point of Care Diagnostics Market Breakdown, by Product
    - 11.3.7.4.2 France: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
    - 11.3.7.4.3 France: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
    - 11.3.7.4.4 France: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
    - 11.3.7.4.5 France: Point of Care Diagnostics Market Breakdown, by Purchase Mode
    - 11.3.7.4.6 France: Point of Care Diagnostics Market Breakdown, by Sample
    - 11.3.7.4.7 France: Point of Care Diagnostics Market Breakdown, by End User
    - 11.3.7.4.8 France: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
  - 11.3.7.5 Italy: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
    - 11.3.7.5.1 Italy: Point of Care Diagnostics Market Breakdown, by Product
    - 11.3.7.5.2 Italy: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
    - 11.3.7.5.3 Italy: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
    - 11.3.7.5.4 Italy: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
    - 11.3.7.5.5 Italy: Point of Care Diagnostics Market Breakdown, by Purchase Mode
    - 11.3.7.5.6 Italy: Point of Care Diagnostics Market Breakdown, by Sample
    - 11.3.7.5.7 Italy: Point of Care Diagnostics Market Breakdown, by End User
    - 11.3.7.5.8 Italy: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
  - 11.3.7.6 Spain: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
    - 11.3.7.6.1 Spain: Point of Care Diagnostics Market Breakdown, by Product
    - 11.3.7.6.2 Spain: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
    - 11.3.7.6.3 Spain: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
    - 11.3.7.6.4 Spain: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
    - 11.3.7.6.5 Spain: Point of Care Diagnostics Market Breakdown, by Purchase Mode
    - 11.3.7.6.6 Spain: Point of Care Diagnostics Market Breakdown, by Sample
    - 11.3.7.6.7 Spain: Point of Care Diagnostics Market Breakdown, by End User
    - 11.3.7.6.8 Spain: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
  - 11.3.7.7 Rest of Europe: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
    - 11.3.7.7.1 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Product
    - 11.3.7.7.2 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
    - 11.3.7.7.3 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
    - 11.3.7.7.4 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
    - 11.3.7.7.5 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Purchase Mode
    - 11.3.7.7.6 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Sample
    - 11.3.7.7.7 Rest of Europe: Point of Care Diagnostics Market Breakdown, by End User
    - 11.3.7.7.8 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.4 Asia Pacific
- 11.4.1 Asia PacificPoint of Care Diagnostics Market Overview
- 11.4.2 Asia Pacific: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
- 11.4.3 Asia Pacific: Point of Care Diagnostics Market Breakdown, by Product
  - 11.4.3.1 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Product
  - 11.4.3.2 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Glucose Monitoring
  - 11.4.3.3 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Infectious Disease Testing
  - 11.4.3.4 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Cardio Metabolic Testing
- 11.4.4 Asia Pacific: Point of Care Diagnostics Market Breakdown, by Purchase Mode
  - 11.4.4.1 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Purchase Mode
- 11.4.5 Asia Pacific: Point of Care Diagnostics Market Breakdown, by Sample
  - 11.4.5.1 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Sample
- 11.4.6 Asia Pacific: Point of Care Diagnostics Market Breakdown, by End User
  - 11.4.6.1 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by End User
  - 11.4.6.2 Asia Pacific: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Healthcare Facilities
- 11.4.7 Asia Pacific: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 11.4.7.1 Asia Pacific: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 11.4.7.2 China: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
    - 11.4.7.2.1 China: Point of Care Diagnostics Market Breakdown, by Product
    - 11.4.7.2.2 China: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
    - 11.4.7.2.3 China: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
    - 11.4.7.2.4 China: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
    - 11.4.7.2.5 China: Point of Care Diagnostics Market Breakdown, by Purchase Mode
    - 11.4.7.2.6 China: Point of Care Diagnostics Market Breakdown, by Sample
    - 11.4.7.2.7 China: Point of Care Diagnostics Market Breakdown, by End User
    - 11.4.7.2.8 China: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
  - 11.4.7.3 Japan: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
    - 11.4.7.3.1 Japan: Point of Care Diagnostics Market Breakdown, by Product
    - 11.4.7.3.2 Japan: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
    - 11.4.7.3.3 Japan: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
    - 11.4.7.3.4 Japan: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
    - 11.4.7.3.5 Japan: Point of Care Diagnostics Market Breakdown, by Purchase Mode
    - 11.4.7.3.6 Japan: Point of Care Diagnostics Market Breakdown, by Sample
    - 11.4.7.3.7 Japan: Point of Care Diagnostics Market Breakdown, by End User
    - 11.4.7.3.8 Japan: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
  - 11.4.7.4 India: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
    - 11.4.7.4.1 India: Point of Care Diagnostics Market Breakdown, by Product
    - 11.4.7.4.2 India: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
    - 11.4.7.4.3 India: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
    - 11.4.7.4.4 India: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
    - 11.4.7.4.5 India: Point of Care Diagnostics Market Breakdown, by Purchase Mode
    - 11.4.7.4.6 India: Point of Care Diagnostics Market Breakdown, by Sample
    - 11.4.7.4.7 India: Point of Care Diagnostics Market Breakdown, by End User
    - 11.4.7.4.8 India: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
  - 11.4.7.5 Australia: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
    - 11.4.7.5.1 Australia: Point of Care Diagnostics Market Breakdown, by Product
    - 11.4.7.5.2 Australia: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
    - 11.4.7.5.3 Australia: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
    - 11.4.7.5.4 Australia: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
    - 11.4.7.5.5 Australia: Point of Care Diagnostics Market Breakdown, by Purchase Mode
    - 11.4.7.5.6 Australia: Point of Care Diagnostics Market Breakdown, by Sample
    - 11.4.7.5.7 Australia: Point of Care Diagnostics Market Breakdown, by End User
    - 11.4.7.5.8 Australia: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
  - 11.4.7.6 South Korea: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
    - 11.4.7.6.1 South Korea: Point of Care Diagnostics Market Breakdown, by Product
    - 11.4.7.6.2 South Korea: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
    - 11.4.7.6.3 South Korea: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
    - 11.4.7.6.4 South Korea: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
    - 11.4.7.6.5 South Korea: Point of Care Diagnostics Market Breakdown, by Purchase Mode
    - 11.4.7.6.6 South Korea: Point of Care Diagnostics Market Breakdown, by Sample
    - 11.4.7.6.7 South Korea: Point of Care Diagnostics Market Breakdown, by End User
    - 11.4.7.6.8 South Korea: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
  - 11.4.7.7 Rest of APAC: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
    - 11.4.7.7.1 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Product
    - 11.4.7.7.2 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
    - 11.4.7.7.3 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
    - 11.4.7.7.4 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
    - 11.4.7.7.5 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Purchase Mode
    - 11.4.7.7.6 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Sample
    - 11.4.7.7.7 Rest of APAC: Point of Care Diagnostics Market Breakdown, by End User
    - 11.4.7.7.8 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.5 Middle East and Africa
- 11.5.1 Middle East and AfricaPoint of Care Diagnostics Market Overview
- 11.5.2 Middle East and Africa: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
- 11.5.3 Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Product
  - 11.5.3.1 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Product
  - 11.5.3.2 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Glucose Monitoring
  - 11.5.3.3 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Infectious Disease Testing
  - 11.5.3.4 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Cardio Metabolic Testing
- 11.5.4 Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Purchase Mode
  - 11.5.4.1 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Purchase Mode
- 11.5.5 Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Sample
  - 11.5.5.1 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Sample
- 11.5.6 Middle East and Africa: Point of Care Diagnostics Market Breakdown, by End User
  - 11.5.6.1 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by End User
  - 11.5.6.2 Middle East and Africa: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Healthcare Facilities
- 11.5.7 Middle East and Africa: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 11.5.7.1 Middle East and Africa: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 11.5.7.2 South Africa: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
    - 11.5.7.2.1 South Africa: Point of Care Diagnostics Market Breakdown, by Product
    - 11.5.7.2.2 South Africa: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
    - 11.5.7.2.3 South Africa: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
    - 11.5.7.2.4 South Africa: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
    - 11.5.7.2.5 South Africa: Point of Care Diagnostics Market Breakdown, by Purchase Mode
    - 11.5.7.2.6 South Africa: Point of Care Diagnostics Market Breakdown, by Sample
    - 11.5.7.2.7 South Africa: Point of Care Diagnostics Market Breakdown, by End User
    - 11.5.7.2.8 South Africa: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
  - 11.5.7.3 Saudi Arabia: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
    - 11.5.7.3.1 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Product
    - 11.5.7.3.2 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
    - 11.5.7.3.3 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
    - 11.5.7.3.4 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
    - 11.5.7.3.5 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Purchase Mode
    - 11.5.7.3.6 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Sample
    - 11.5.7.3.7 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by End User
    - 11.5.7.3.8 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
  - 11.5.7.4 United Arab Emirates: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
    - 11.5.7.4.1 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Product
    - 11.5.7.4.2 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
    - 11.5.7.4.3 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
    - 11.5.7.4.4 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
    - 11.5.7.4.5 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Purchase Mode
    - 11.5.7.4.6 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Sample
    - 11.5.7.4.7 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by End User
    - 11.5.7.4.8 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
  - 11.5.7.5 Rest of Middle East and Africa: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
    - 11.5.7.5.1 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Product
    - 11.5.7.5.2 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
    - 11.5.7.5.3 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
    - 11.5.7.5.4 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
    - 11.5.7.5.5 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Purchase Mode
    - 11.5.7.5.6 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Sample
    - 11.5.7.5.7 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by End User
    - 11.5.7.5.8 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
11.6 South and Central America
- 11.6.1 South and Central America Point of Care Diagnostics Market Overview
- 11.6.2 South and Central America: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
- 11.6.3 South and Central America: Point of Care Diagnostics Market Breakdown, by Product
  - 11.6.3.1 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Product
  - 11.6.3.2 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Glucose Monitoring
  - 11.6.3.3 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Infectious Disease Testing
  - 11.6.3.4 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Cardio Metabolic Testing
- 11.6.4 South and Central America: Point of Care Diagnostics Market Breakdown, by Purchase Mode
  - 11.6.4.1 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Purchase Mode
- 11.6.5 South and Central America: Point of Care Diagnostics Market Breakdown, by Sample
  - 11.6.5.1 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Sample
- 11.6.6 South and Central America: Point of Care Diagnostics Market Breakdown, by End User
  - 11.6.6.1 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by End User
  - 11.6.6.2 South and Central America: Point of Care Diagnostics Market- Revenue and Forecast Analysis - by Healthcare Facilities
- 11.6.7 South and Central America: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 11.6.7.1 South and Central America: Point of Care Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 11.6.7.2 Brazil: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
    - 11.6.7.2.1 Brazil: Point of Care Diagnostics Market Breakdown, by Product
    - 11.6.7.2.2 Brazil: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
    - 11.6.7.2.3 Brazil: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
    - 11.6.7.2.4 Brazil: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
    - 11.6.7.2.5 Brazil: Point of Care Diagnostics Market Breakdown, by Purchase Mode
    - 11.6.7.2.6 Brazil: Point of Care Diagnostics Market Breakdown, by Sample
    - 11.6.7.2.7 Brazil: Point of Care Diagnostics Market Breakdown, by End User
    - 11.6.7.2.8 Brazil: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
  - 11.6.7.3 Argentina: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
    - 11.6.7.3.1 Argentina: Point of Care Diagnostics Market Breakdown, by Product
    - 11.6.7.3.2 Argentina: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
    - 11.6.7.3.3 Argentina: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
    - 11.6.7.3.4 Argentina: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
    - 11.6.7.3.5 Argentina: Point of Care Diagnostics Market Breakdown, by Purchase Mode
    - 11.6.7.3.6 Argentina: Point of Care Diagnostics Market Breakdown, by Sample
    - 11.6.7.3.7 Argentina: Point of Care Diagnostics Market Breakdown, by End User
    - 11.6.7.3.8 Argentina: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities
  - 11.6.7.4 Rest of South and Central America: Point of Care Diagnostics Market - Revenue, 2021 - 2031 (US$ Million)
    - 11.6.7.4.1 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Product
    - 11.6.7.4.2 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring
    - 11.6.7.4.3 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing
    - 11.6.7.4.4 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing
    - 11.6.7.4.5 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Purchase Mode
    - 11.6.7.4.6 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Sample
    - 11.6.7.4.7 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by End User
    - 11.6.7.4.8 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities

12. Competitive Landscape

12.1 Heat Map Analysis by Key Players
12.2 Company Market Share Analysis, 2024

13. Industry Landscape

13.1 Overview
13.2 Market Initiative
13.3 Merger and Acquisition

14. Company Profiles

14.1 F. Hoffmann-La Roche Ltd
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Beckman Coulter Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Bio-Rad Laboratories Inc
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Abbott Laboratories
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Johnson & Johnson
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Siemens AG
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 BD
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 bioMerieux SA
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Polymer Technology Systems, Inc. (PTS)
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Nova Biomedical Corporation
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Talis Biomedical Corporation
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments
14.12 QuidelOrtho Corp
- 14.12.1 Key Facts
- 14.12.2 Business Description
- 14.12.3 Products and Services
- 14.12.4 Financial Overview
- 14.12.5 SWOT Analysis
- 14.12.6 Key Developments
14.13 Chembio Diagnostics, Inc.
- 14.13.1 Key Facts
- 14.13.2 Business Description
- 14.13.3 Products and Services
- 14.13.4 Financial Overview
- 14.13.5 SWOT Analysis
- 14.13.6 Key Developments

15. Appendix

15.1 About The Insight Partners